Beta-Defensin vs Thymulin
A side-by-side research comparison of Beta-Defensin and Thymulin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Beta-Defensin | Thymulin |
|---|---|---|
| Full name | Human Beta-Defensin Peptides | Thymulin (Facteur Thymique Serique) |
| Category | Immune Support | Immune Support |
| Status | Research compound | Research compound |
| Mechanism | Form pores in microbial membranes causing lysis, recruit immune cells via CCR6 receptor chemotaxis, and bridge innate and adaptive immunity by activating dendritic cells. | Binds to specific receptors on T-cell precursors promoting their differentiation into mature T-cells, modulates cytokine production, and requires zinc as cofactor. |
| Molecular weight | 4000-5000 Da | 847.9 Da |
| Half-life | ~2-4 hours | ~2 hours |
| Bioavailability | Primarily local/mucosal activity | ~80% subcutaneous |
| Typical dose | 50-200 mcg | 1-5 mg |
| Frequency | Daily or as needed | 2-3x per week |
| Route | Topical or subcutaneous | Subcutaneous injection |
Beta-Defensin reported benefits
- Broad antimicrobial activity
- Immune cell recruitment
- Wound healing support
- Biofilm disruption
Thymulin reported benefits
- T-cell maturation support
- Thymic function restoration
- Zinc-dependent immune activation
- Anti-inflammatory properties
Related comparisons
Research and educational reference only. Not medical advice.